Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc….
Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc….
Sotagliflozin reduced the risk of cardiovascular death and heart failure readmissions in patients hospitalized for…
On track to provide clinical update for RUBY trial by mid-2023 and dose 20 total…
On track to provide clinical update for RUBY trial by mid-2023 and dose 20 total…
Add-on value-added service provides ultra-fast, ultra-reliable, and cost-efficient connectivity to enterprise, industrial, and transportation critical…
– Investment will advance Epic’s lead program, EPI-321, toward clinic in 2024 – SOUTH SAN…
– Investment will advance Epic’s lead program, EPI-321, toward clinic in 2024 – SOUTH SAN…
Novel Technology Identified Genes that Promote T Cell Exhaustion, and which are Unique from PD-1/PD-L1…
Novel Technology Identified Genes that Promote T Cell Exhaustion, and which are Unique from PD-1/PD-L1…
Improved ADCC with ADAM17 gene knockout of NK or CAR NK cells, supporting ADAM17 KO…
BOSTON, April 14, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the…
BOSTON, April 14, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the…
ngenea®2, combined with Kalray’s software-defined storage solution (pixstor) and Kalray’s processors (Coolidge), opens new horizons…
Elliott Levy, M.D. Editas Medicine announced the appointment of Elliott Levy, M.D., to its Board…
Elliott Levy, M.D. Editas Medicine announced the appointment of Elliott Levy, M.D., to its Board…
Two allogeneic CAR-NK cell therapies demonstrate significant efficacy in tumor xenograft models Data underscore potential…
Two allogeneic CAR-NK cell therapies demonstrate significant efficacy in tumor xenograft models Data underscore potential…
BOSTON, April 06, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology…
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…